SHARNEL REED: Open Payments
NPI 1609317908 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,609 in 153 payments from 23 companies in 2025. Trend: 2023 $1,653 · 2024 $1,979 · 2025 $2,609
Food & beverage: $2,510Education: $99
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 36 | $575 |
| Janssen Biotech, Inc. | 21 | $371 |
| ABBVIE INC. | 17 | $238 |
| Incyte Corporation | 13 | $203 |
| GENZYME CORPORATION | 6 | $177 |
| Galderma Laboratories, L.P. | 15 | $153 |
| Botanix SB Inc | 9 | $137 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
| PFIZER INC. | 3 | $76 |
| Regeneron Healthcare Solutions, Inc. | 3 | $68 |
Products named: Zoryve, TREMFYA, DUPIXENT, OPZELURA, SKYRIZI, SOFDRA, NEMLUVIO, CIBINQO.
Industry payments across FL — which companies pay providers there.
